12:00 AM
 | 
Jul 15, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Idec Pharmaceuticals Corp.

(IDPH), San Diego, Calif.

Business: Cancer, Autoimmune/Inflammation

Lazard Freres analyst Joel Sendek raised his 2002 and 2003 EPS estimates to $0.82...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >